Skip to main content
Premium Trial:

Request an Annual Quote

De-Extinction Firm Colossal Biosciences Raises $150M in Series B Round


NEW YORK — Colossal Biosciences, which aims to use gene editing and other technologies to restore extinct animal species, said on Tuesday that it has raised $150 million in Series B funding.

The financing round was led by United States Innovative Technology Fund and included Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca Brands, Peak 6, Bold Capital, and Jazz Ventures. Colossal, which launched in late 2021 with $15 million in seed funding and closed a $60 million Series A round about a year ago, has raised $225 million to date.

In conjunction with the Series B announcement, Colossal said that it has formed an avian genomics division that will be focused on restoring and reintroducing the extinct dodo bird. The Dallas-based company is currently working to restore the woolly mammoth and the Tasmanian tiger.

Colossal also recently spun out a new company, called Form Bio, to commercialize its bioinformatics and computational biology technology platform.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.